MEMS-based viscometers for biotech and pharma with minimal sample volume
RheoSense manufactures viscometry instruments using patented microfluidics technology, targeting biotech and pharmaceutical R&D labs. The tech stack is Windows-centric (.NET, C#, WinForms, WPF) with SQL Server backend and hardware integration via USB/CAN/Ethernet — typical of embedded lab instrumentation. Active hiring across sales, engineering, and manufacturing, combined with projects around ERP migration and omni-channel GTM expansion, suggests the company is scaling production and distribution beyond its core biotech customer base.
RheoSense designs and sells viscometers and rheometers built on proprietary Viscometer/Rheometer-on-Chip (VROC) technology. The instruments are optimized for small-volume samples and precision measurement, serving biotech, pharmaceutical, and protein therapeutics research. The company operates from San Ramon, California, with 11–50 employees across engineering, manufacturing, sales, and support functions. Current operational priorities include transitioning ERP systems (away from QuickBooks), expanding into adjacent market segments, and developing marketing automation and omni-channel strategies for life sciences audiences.
Viscometer/Rheometer-on-Chip (VROC) — a patented MEMS and microfluidics platform that enables viscosity measurement with minimal sample volume and high accuracy.
Windows/.NET ecosystem (C#, WinForms, WPF, XAML), SQL Server and SQLite databases, hardware integration via USB/CAN/Ethernet, with Salesforce and HubSpot for sales/marketing operations.
Primarily the United States and United Kingdom. Active openings span sales (5), engineering (4), manufacturing (2), finance (2), support (2), and single roles in marketing and ops.
Other companies in the same industry, closest in size